Shopping Cart 0
Cart Subtotal
USD 0

Advanced Accelerator Applications SA - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company's lead product candidate comprises Lutathera, NETSPOT, SOMAKIT TOC, Gluscan, Gluscan 500, Barnascan, Fluorochol, AAACholine, Cholscan, MIBITEC, Adamibi, Leukokit, Neurolite and Lumark. AAA develops new medicines which targets the orphan diseases in the field of cardiology, oncology, neurology and inflammation. It is also engaged in manufacturing Positron Emission tomography (PET) and single-photon emission computed tomography (SPECT). The company operates in France, Italy, the UK, Germany, Switzerland, Spain, Poland, Portugal, Israel, the US, and Canada, among others. AAA is headquartered in Saint-Genis-Pouilly, Auvergne, France.

Advanced Accelerator Applications SA-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Advanced Accelerator Applications SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Advanced Accelerator Applications SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Advanced Accelerator Applications SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Advanced Accelerator Applications SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Advanced Accelerator Applications SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Advanced Accelerator Applications SA, Medical Equipment, Deal Details 12

Asset Purchase 12

Advanced Accelerator Applications to Acquire Two Production Sites in Germany 12

Advanced Accelerator Applications Acquires Positron Emission Tomography from GE Healthcare 13

Venture Financing 14

Advanced Accelerator Applications Raises USD 56 Million In Venture Financing 14

Advanced Accelerator Raises USD 6 Million In First Tranche Of Venture Financing 15

Partnerships 16

Advanced Accelerator Applications Enters into Distribution Agreement with Blue Earth Diagnostics 16

Itel Telecomunicazioni Enters into Agreement with Advanced Accelerator Applications 17

Eveon Enters into Agreement with Advanced Accelerator Applications 18

Advanced Accelerator Applications Enters Into Co-Development Agreement With University of Warsaw 19

Advanced Accelerator Enters into Licensing Agreement with Cancer Targeted Technology 20

Equity Offering 21

Advanced Accelerator Applications Prices Public Offering of American Depositary Shares for USD172.5 Million 21

Advanced Accelerator Applications to Raise up to USD80 Million in IPO 23

Acquisition 25

Novartis Acquires Advanced Accelerator Applications for USD3.9 Billion 25

Advanced Accelerator Applications Acquires Remaining 49.9% Stake in Umbra Medical 27

Advanced Accelerator Applications Acquires Imaging Equipment 28

Advanced Accelerator Applications Acquires Barnatron 29

Advanced Accelerator Applications Acquires Catalana De Dispensacion 30

Advanced Accelerator Applications SA-Key Competitors 31

Advanced Accelerator Applications SA-Key Employees 32

Advanced Accelerator Applications SA-Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 35

Strategy And Business Planning 35

May 17, 2018: SNMMI Collaborates with Industry to Advance the Field of Nuclear Medicine and Molecular Imaging 35

Financial Announcements 36

Nov 17, 2017: Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017 36

May 31, 2017: Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017 37

Mar 23, 2017: Advanced Accelerator Applications Reports 23% Sales Growth for Fiscal 2016; Continued NETSPOT Launch Success 39

Corporate Communications 41

May 25, 2017: Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors 41

Other Significant Developments 42

Jan 09, 2017: Advanced Accelerator Applications CEO Provides Progress Report on Corporate Developments of 2016; Asserts Confidence in Ability to Address FDA Comments on Lutathera NDA 42

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Advanced Accelerator Applications SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Advanced Accelerator Applications SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Advanced Accelerator Applications SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Advanced Accelerator Applications SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Advanced Accelerator Applications SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Advanced Accelerator Applications SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Advanced Accelerator Applications SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Advanced Accelerator Applications SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Advanced Accelerator Applications SA, Medical Equipment, Key Facts 2

Advanced Accelerator Applications SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Advanced Accelerator Applications SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Advanced Accelerator Applications SA, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Advanced Accelerator Applications SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Advanced Accelerator Applications SA, Deals By Market, 2012 to YTD 2018 9

Advanced Accelerator Applications SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Advanced Accelerator Applications to Acquire Two Production Sites in Germany 12

Advanced Accelerator Applications Acquires Positron Emission Tomography from GE Healthcare 13

Advanced Accelerator Applications Raises USD 56 Million In Venture Financing 14

Advanced Accelerator Raises USD 6 Million In First Tranche Of Venture Financing 15

Advanced Accelerator Applications Enters into Distribution Agreement with Blue Earth Diagnostics 16

Itel Telecomunicazioni Enters into Agreement with Advanced Accelerator Applications 17

Eveon Enters into Agreement with Advanced Accelerator Applications 18

Advanced Accelerator Applications Enters Into Co-Development Agreement With University of Warsaw 19

Advanced Accelerator Enters into Licensing Agreement with Cancer Targeted Technology 20

Advanced Accelerator Applications Prices Public Offering of American Depositary Shares for USD172.5 Million 21

Advanced Accelerator Applications to Raise up to USD80 Million in IPO 23

Novartis Acquires Advanced Accelerator Applications for USD3.9 Billion 25

Advanced Accelerator Applications Acquires Remaining 49.9% Stake in Umbra Medical 27

Advanced Accelerator Applications Acquires Imaging Equipment 28

Advanced Accelerator Applications Acquires Barnatron 29

Advanced Accelerator Applications Acquires Catalana De Dispensacion 30

Advanced Accelerator Applications SA, Key Competitors 31

Advanced Accelerator Applications SA, Key Employees 32

Advanced Accelerator Applications SA, Subsidiaries 33

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Advanced Accelerator Applications SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.